A comprehensive database providing the average cost of chemotherapy and cytostatic hormonal treatment.
IMS Oncology Cost of Treatment provides average costs of cytostatics and cytostatic hormones, based on average dose given per cycle/patient, average number of cycles given/patient and price/mg using non-discounted pricing.
IMS Oncology Cost of Treatment is based on a bottom up approach, utilizing Oncology Analyzer's projected patients for the top five European countries and Japan, average dose/patient/cycle, average duration/patient (cycles or days where applicable) and average price.
IMS Oncology Cost of Treatment covers France, Germany, Italy, Spain, UK and Japan and comprises:
-
Entire chemotherapy market across all tumors by country
-
Entire hormonal market in breast and prostate cancer
